BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tampi RR, Tampi DJ, Young JJ, Balachandran S, Hoq RA, Manikkara G. Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis. World J Psychiatr 2019; 9(3): 47-54 [PMID: 31211112 DOI: 10.5498/wjp.v9.i3.47]
URL: https://www.wjgnet.com/1948-5182/full/v9/i3/47.htm
Number Citing Articles
1
Karun Badwal, Shangwe A. Kiliaki, Sagar B. Dugani, Sandeep R. Pagali. Psychosis Management in Lewy Body Dementia: A Comprehensive Clinical ApproachJournal of Geriatric Psychiatry and Neurology 2022; 35(3): 255 doi: 10.1177/0891988720988916
2
Milagros Rojas, Mervin Chávez-Castillo, Pablo Duran, Ángel Ortega, María Judith Bautista-Sandoval, Juan Salazar, Manuel Riaño-Garzón, Maricarmen Chacín, Oscar Medina-Ortiz, Jim Palmar, Lorena Cudris-Torres, Valmore Bermúdez. Psychosis in Parkinson’s Disease: Looking Beyond Dopaminergic TreatmentsCurrent Pharmaceutical Design 2022; 28(33): 2725 doi: 10.2174/1381612828666220428102802
3
Valentina Bashkatova. Metabotropic glutamate receptors and nitric oxide in dopaminergic neurotoxicityWorld Journal of Psychiatry 2021; 11(10): 830-840 doi: 10.5498/wjp.v11.i10.830
4
Sweta Bhoopatiraju, George Grossberg. Emerging Perspectives in the Diagnosis and Management of Depression and Psychosis in Parkinson's DiseaseNeurology 2021; 17(2): 97 doi: 10.17925/USN.2021.17.2.97
5
Shuo Zhang, Yan Ma. Emerging role of psychosis in Parkinson's disease: From clinical relevance to molecular mechanismsWorld Journal of Psychiatry 2022; 12(9): 1127-1140 doi: 10.5498/wjp.v12.i9.1127
6
Jie Liu, Dongdong Peng, Jinlong Li, Zong Dai, Xiaoyong Zou, Zhanchao Li. Identification of Potential Parkinson’s Disease Drugs Based on Multi-Source Data Fusion and Convolutional Neural NetworkMolecules 2022; 27(15): 4780 doi: 10.3390/molecules27154780
7
Xiaoyin Zhu, Yue Yang, Guangying Du, Bin Liu, Xin Yu, Liang Ye, Yutong Mao, Hongbo Wang, Jingwei Tian. Non-clinical pharmacology and toxicology studies of LPM6690061, a novel 5-hydroxytryptamine (5-HT)2A receptor inverse agonistFood and Chemical Toxicology 2023; 176: 113800 doi: 10.1016/j.fct.2023.113800
8
Yung-Chih Kuo, He-Cheng Tsai, Rajendiran Rajesh. Glutathione Liposomes Carrying Ceftriaxone, FK506, and Nilotinib to Control Overexpressed Dopamine Markers and Apoptotic Factors in NeuronsACS Biomaterials Science & Engineering 2021; 7(7): 3242 doi: 10.1021/acsbiomaterials.1c00555
9
Sagar Suman Panda, Ravi kumar Venkata Varaha Bera, Jnyanaranjan Panda. Chemometry-assisted Diffuse Reflectance Infrared Fourier Transform Spectroscopy (DRIFTS) method for quantification of a novel antipsychotic agent in pharmaceuticals: A case study on ICH Q 14 conceptVibrational Spectroscopy 2020; 107: 103039 doi: 10.1016/j.vibspec.2020.103039
10
Mark David Tricklebank, Trevor W. Robbins, Camilla Simmons, Erik H. F. Wong. Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacologyPsychopharmacology 2021; 238(6): 1417 doi: 10.1007/s00213-021-05787-x
11
Saloni Seth, Saurabh Saurabh, Dinesh Kataria, Shiv Prasad, Prerna Kukreti. NEUROPSYCHIATRIC ASPECTS OF MOVEMENT DISORDERSINDIAN JOURNAL OF APPLIED RESEARCH 2022; : 28 doi: 10.36106/ijar/1901380